drugset / Trial / NCT07647198

FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

NCT07647198

Phase 2 Recruiting 240 enrolled Sheikh Shakhbout Medical City
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this randomized controlled clinical trial is to evaluate the efficacy of green tea (EGCG) and vitamin D3 supplementation in preventing uterine fibroid recurrence following fibroid removal.

Timeline

Start
2026-08-22
Primary completion
2029-08-22
Completion
2029-12-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 2000 iu Oral
Subject Epigallocatechin gallate Small molecule 300 mg Oral

Indications